Loading...
•
Dec 31, 2025
GE HealthCare Q4 2025 Earnings Report
Reported solid fourth-quarter results with revenue growth and resilient operations despite tariff-related margin pressure.
Key Takeaways
GE HealthCare delivered revenue growth in Q4 2025 driven by Imaging and Pharmaceutical Diagnostics, while profitability declined year over year due to tariffs and unfavorable mix.
Revenue increased year over year, supported by Imaging and PDx growth.
Adjusted EBIT margin declined due to tariff impacts.
Earnings per share decreased compared to the prior year quarter.
Strong cash generation supported liquidity and balance sheet strength.
Revenue by Segment
Forward Guidance
The company introduced full-year 2026 guidance reflecting continued growth and margin expansion.
Positive Outlook
- Expected organic revenue growth of 3.0% to 4.0%.
- Adjusted EBIT margin projected to expand year over year.
- Adjusted EPS growth anticipated for 2026.
- Free cash flow expected to improve to approximately $1.7 billion.
- Lower tariff impact expected compared to 2025.
Challenges Ahead
- Ongoing macroeconomic uncertainty.
- Potential volatility from foreign exchange movements.
- Residual tariff and trade policy risks.
- Continued pressure from input costs.
- Execution risk related to acquisitions and integration.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...